KDR and gastric cancer: For instance, human epidermal growth factor receptor 2 (HER2) and vascular endothelial growth factor receptor (VEGFR) are two key prognostic biomarkers in GC [10, 11] and their monoclonal antibodies have been widely used to treat advanced GC patients and bring much survival benefit [12].